Blast Phase (Disease Or Phenotype)

Nci:C9110

Msh:D001752

Mondo:MONDO:6115

Medcin:MEDCIN:351070

Mdr:MDR:10053747

Id:314d6c30-dceb-5136-8e5c-e45a3a41b3d6

Efo:EFO:1000131

Chv:CHV:1958

Linked to

	Label	Description
	N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide indication Blast Phase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	imatinib indication Blast Phase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	SKI-606 indication Blast Phase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	WP811 indication Blast Phase Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide indication Blast Phase

A Knowledge Graph Assertion from IDG

imatinib indication Blast Phase

A Knowledge Graph Assertion from IDG

SKI-606 indication Blast Phase

A Knowledge Graph Assertion from IDG

WP811 indication Blast Phase

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025